Dominique Heymann spends much of his time researching Osteoclast, RANKL, Cancer research, Internal medicine and Osteosarcoma. His studies deal with areas such as Stromal cell, Bone cell, Biophysics, Bone remodeling and Resorption as well as Osteoclast. Dominique Heymann works mostly in the field of RANKL, limiting it down to topics relating to Osteoprotegerin and, in certain cases, Immunology and Osteolysis, as a part of the same area of interest.
His studies in Cancer research integrate themes in fields like Cytokine, Cell growth, Cancer cell, Apoptosis and Single-cell analysis. His study in Endocrinology extends to Internal medicine with its themes. His Osteosarcoma research is included under the broader classification of Pathology.
Dominique Heymann mainly investigates Cancer research, Osteosarcoma, Pathology, Internal medicine and RANKL. His Cancer research research is multidisciplinary, incorporating elements of Cell culture, Cancer cell, Immunology, Tumor progression and In vivo. His study in Osteosarcoma is interdisciplinary in nature, drawing from both Osteolysis, Cell growth, Metastasis, Sarcoma and Primary bone.
Dominique Heymann combines subjects such as Endocrinology and Oncology with his study of Internal medicine. He has included themes like Osteoclast and Osteoprotegerin in his RANKL study. Dominique Heymann interconnects Bone cell, Cell biology and Bone remodeling in the investigation of issues within Bone resorption.
Osteosarcoma, Cancer research, Cancer, Cancer cell and Internal medicine are his primary areas of study. His Osteosarcoma research integrates issues from Cell culture, Osteolysis, Mesenchymal stem cell and Sarcoma. His study looks at the relationship between Osteolysis and topics such as Bone remodeling, which overlap with Bone resorption.
His work deals with themes such as Chemotherapy, Metastasis, Circulating tumor cell, microRNA and In vivo, which intersect with Cancer research. His Internal medicine research is multidisciplinary, incorporating perspectives in Endocrinology and Oncology. RANKL is closely connected to Tumor microenvironment in his research, which is encompassed under the umbrella topic of Osteoprotegerin.
Dominique Heymann focuses on Osteosarcoma, Disease, Cancer, Cancer research and Circulating tumor cell. His research integrates issues of Tumor microenvironment, Chondrosarcoma, Sarcoma and RANKL in his study of Osteosarcoma. His Disease study is concerned with Internal medicine in general.
His work on Cancer cell and Acquired resistance is typically connected to Multidrug tolerance as part of general Cancer study, connecting several disciplines of science. His Cancer cell study also includes
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
The molecular triad OPG/RANK/RANKL: involvement in the orchestration of pathophysiological bone remodeling.
Sandrine Theoleyre;Yohann Wittrant;Steeve Kwan Tat;Yannick Fortun.
Cytokine & Growth Factor Reviews (2004)
Osteoclastic resorption of calcium phosphate ceramics with different hydroxyapatite/β-tricalcium phosphate ratios
S Yamada;D Heymann;J M Bouler;G Daculsi.
Recent advances in TGF-beta effects on chondrocyte metabolism. Potential therapeutic roles of TGF-beta in cartilage disorders.
Eva Grimaud;Dominique Heymann;Françoise Rédini.
Cytokine & Growth Factor Reviews (2002)
Induction of Osteogenesis in Mesenchymal Stem Cells by Activated Monocytes/Macrophages Depends on Oncostatin M Signaling
P. Guihard;P. Guihard;Y. Danger;B. Brounais;B. Brounais;E. David;E. David.
Stem Cells (2012)
Mechanisms of bone repair and regeneration.
Frédéric Deschaseaux;Luc Sensébé;Dominique Heymann.
Trends in Molecular Medicine (2009)
Receptor Activator of Nuclear Factor κB Ligand (RANKL)/Osteoprotegerin (OPG) Ratio Is Increased in Severe Osteolysis
Eva Grimaud;Luc Soubigou;Séverine Couillaud;Patrick Coipeau.
American Journal of Pathology (2003)
Human breast cancer cells educate macrophages toward the M2 activation status
Sofia Sousa;Régis Brion;Régis Brion;Minnamaija Lintunen;Pauliina Kronqvist.
Breast Cancer Research (2015)
Autophagy in osteoblasts is involved in mineralization and bone homeostasis.
Marie Nollet;Sabine Santucci-Darmanin;Véronique Breuil;Rasha Al-Sahlanee.
RANKL/RANK/OPG: new therapeutic targets in bone tumours and associated osteolysis.
Yohann Wittrant;Sandrine Théoleyre;Céline Chipoy;Marc Padrines.
Biochimica et Biophysica Acta (2004)
Osteoclastic acidification pathways during bone resorption.
A.-V Rousselle;D Heymann.
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: